90484-47-2Relevant academic research and scientific papers
FUSED TRICYCLIC COMPOUNDS AS RAF KINASE INHIBITORS
-
Paragraph 0209; 0339; 0344-0345, (2021/02/16)
Provided are certain fused tricyclic compounds and salts thereof, compositions thereof, and methods of use therefor.
Condensed tricyclic compounds as RAF kinase inhibitors
-
Paragraph 0358; 0565; 0566; 0573; 0574; 0575, (2016/10/07)
The invention provides certain condensed tricyclic compounds as well as salt, compositions and application methods thereof.
CONDENSED TRICYCLIC COMPOUNDS AS Raf KINASE INHIBITORS
-
Paragraph 0212; 0215, (2017/01/05)
PROBLEM TO BE SOLVED: To provide specific tricyclic compounds that can be useful for inhibiting Raf kinase and for treating disorders mediated by Raf kinase. SOLUTION: A compound is represented by the general formula 1 in the figure. (Q is C or N; W is C or N; X is CH2 or O; Y is NR12, O or S; Z is O, S, NR13, CO, SO, SO2 or CR13R14; R1 to R6 are each independently hydrogen, halogen, haloalkyl, alkyl or the like.) SELECTED DRAWING: None COPYRIGHT: (C)2017,JPO&INPIT
FUSED TRICYCLIC COMPOUNDS AS RAF KINASE INHIBITORS
-
Paragraph 0378; 0383-0384, (2015/02/25)
Provided are certain fused tricyclic compounds and salts thereof, compositions thereof, and methods of use therefor.
FUSED TRICYCLIC AMIDE COMPOUNDS AS MULTIPLE KINASE INHIBITORS
-
Page/Page column 107; 108, (2015/01/16)
Provided are fused tricyclic amide compounds, pharmaceutical compositions comprising at least one such fused tricyclic compound, processes for the preparation thereof, and the use thereof in therapy. Disclosed herein are certain tricyclic amide compounds that can be useful for inhibiting multiple (specifically BRAF and/or EGFR-T790M) kinases and for treating disorders mediated thereby.
FUSED TRICYCLIC COMPOUNDS AS RAF KINASE INHIBITORS
-
Page/Page column 73, (2013/07/19)
Provided are certain fused tricyclic compounds and salts thereof, compositions thereof, and methods of use therefor.
Aminoalkylbenzofurans as serotonin (5-HT(2c)) agonists
-
Page/Page column 21, (2010/11/08)
The present invention provides serotonergic aminoalkylbenzofurans of Formula (I): where R, R1, R2, R3, R4, R4′, R5, R5′, and R12 are as described in the specification.
SEROTONERGIC BENZOFURANS
-
Page/Page column 16, (2010/02/04)
The present invention provides serotonergic benzofurans of Formula (I): where A, R, R, R, R, and R are as described in the specification.
BENZOFURYLPIPERAZINES AND BENZOFURYLHOMOPIPERAZINES: SEROTONIN AGONISTS
-
, (2013/12/12)
The present invention provides serotonergic benzofurylpiperazines of Formula I: where: A is a piperazine of formula: and R, R1, R2, R3, R4, R5, R5', R6, R6', R7, R7', R8, and R8' are as described in the specification.
